Animal disease: Probiotic solution to promote...
Animal disease

Probiotic solution to promote intestinal resilience in poultry and livestock

Imago / Science Photo Library
Intestinal resilience is a crucial factor in producers’ hierarchy of needs for their animals. With its latest product, Kemin aims to promote intestinal resilience to prevent disease before it develops.
Intestinal resilience is a crucial factor in producers’ hierarchy of needs for their animals. With its latest product, Kemin aims to promote intestinal resilience to prevent disease before it develops.

AE, Dubai. Global ingredient manufacturer Kemin Industries announced the launch of its latest product Enterosure, aimed at controlling the growth of pathogenic bacteria in poultry and livestock.

At a global launch event in Dubai, the ingredient supplier unveiled its latest intestinal health product to promote a healthy microbiome, intestinal resilience, gut health and improved animal productivity.


According to the company, enteric disease challenges are an ever-present pressure on livestock and poultry producers, who are already facing significant performance and economic impact from the global trend toward reduced antimicrobial use and the rising cost of raw materials.

“Leveraging the pioneering research that launched Clostat, our novel solution addresses the changing needs of animal producers,” said G.S. Ramesh, Worldwide Group President – Animal Nutrition and Health, Kemin Industries. “Enterosure, through its proprietary blend of probiotic Bacillus strains, expands on the scientifically proven efficacy of Clostat’s Bacillus subtilis PB6 against Clostridium perfringens by also managing the growth of Escherichia coli and other Enterobacteriaceae, such as Salmonella,” Ramesh added.

Managing enteric diseases requires an effective and comprehensive solution that helps drive intestinal resilience to prevent disease before it develops. Up to 80% of antimicrobial use is intended to achieve resilience in the gastrointestinal system, a vital component in animal production. Kemin aims to drive innovation through its probiotic research program to support intestinal health management.

The company undertook a multiyear, global project to discover advanced solutions to enhance intestinal resilience while maintaining a robust program to improve feed conversion and weight gain and combat pathogens that contribute to dysbiosis, diarrhea, wet litter issues, foot-pad lesions and mortality.

Source: Kemin Industries, Inc.

Newsletter-Service

With our free newsletters, we can provide you with the most important industry news and useful practical tips from Germany and around the world.

 
stats